Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $348.47 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $135.00 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $104.76 | 1 | $0 (2023) |
| GENZYME CORPORATION | $35.47 | 1 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $29.85 | 1 | $0 (2020) |
| Lantheus Medical Imaging, Inc. | $23.02 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $20.37 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $170.47 | 2 | PFIZER INC. ($135.00) |
| 2023 | $127.78 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($104.76) |
| 2022 | $20.37 | 1 | Otsuka America Pharmaceutical, Inc. ($20.37) |
| 2020 | $29.85 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($29.85) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $35.47 | General |
| Category: Oncology | ||||||
| 06/02/2024 | PFIZER INC. | LORBRENA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: ONCOLOGY | ||||||
| 05/04/2023 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: CONTRAST AGENT | ||||||
| 03/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $104.76 | General |
| 10/20/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: NEPHROLOGY | ||||||
| 11/12/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $29.85 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
About Ranjit Jasaraj
Ranjit Jasaraj is a Hematology & Oncology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2020. The National Provider Identifier (NPI) number assigned to this provider is 1750994513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ranjit Jasaraj has received a total of $348.47 in payments from pharmaceutical and medical device companies, with $170.47 received in 2024. These payments were reported across 6 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($348.47).
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Internal Medicine
- Location Oklahoma City, OK
- Active Since 08/30/2020
- Last Updated 07/01/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1750994513
Products in Payments
- LORBRENA (Drug) $135.00
- SARCLISA (Biological) $35.47
- LifeVest (Device) $29.85
- DEFINITY (Drug) $23.02
- JYNARQUE (Drug) $20.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Oklahoma City
Robert Reynolds, Md, MD
Hematology & Oncology — Payments: $14,579
Philip Comp, Md, MD
Hematology & Oncology — Payments: $13,151
Dr. Charles Hollen, M.d, M.D
Hematology & Oncology — Payments: $12,135
Jennifer Holter-Chakrabarty, Md, MD
Hematology & Oncology — Payments: $11,994
Dr. Saadia Chohan, Md, MD
Hematology & Oncology — Payments: $11,197
Abby Bova, Md, MD
Hematology & Oncology — Payments: $5,791